Lv1
22 积分 2025-09-17 加入
Ursodeoxycholic acid enhances cancer radioimmunotherapy by releasing a human-biased FXR-TRIM22-STAT1 immune brake
4天前
已完结
Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications
1个月前
已完结
Metabolic immune checkpoints (MICs) in cancer: from molecular mechanisms to challenges and opportunities in clinical translation
1个月前
已完结
Molecular evaluation of residual disease following neoadjuvant chemotherapy in triple-negative breast cancer CALGB 40603 (Alliance)
1个月前
已完结
Metabolic-epigenetic reprogramming via the PLOD1-PFKP axis drives cisplatin resistance in HNSCC
1个月前
已完结
The immunology of human breast cancer
1个月前
已完结
Current and future therapies for triple-negative breast cancer
2个月前
已完结
Current and future therapies for triple-negative breast cancer
2个月前
已完结
Thyroid Tumors of Uncertain Malignant Potential (UMP)- Clinicopathologic and Molecular Characterization of 324 Cases
2个月前
已完结
Histopathologic and Molecular Characterization of Uterine Leiomyoma–like Inflammatory Myofibroblastic Tumor
3个月前
已完结